Company profile: Orange Grove Bio
1.1 - Company Overview
Company description
- Provider of a preclinical drug investment and development platform focused on reducing drug discovery costs and advancing therapies to clinical trials, offering direct sourcing and comprehensive diligence processes, seasoned operations teams, licensing via academic collaborations, and technologies such as Preservation Bio's platelet additive and Genexys BioMed's gene therapy platform.
Products and services
- Comprehensive Diligence Process: A multi-stage evaluation process assessing clinical and financial potential of biomedical assets, guiding go/no-go decisions consistent with OGB’s focus on advancing therapies into clinical trials
- Direct Sourcing Process: A partnership-driven method that identifies and licenses promising biomedical innovations through collaborations with universities and scientists, strengthening OGB’s preclinical pipeline within its investment and development platform
- Seasoned Operations Teams: Expert-led teams that manage pharmaceutical assets through clinical processes and operations to support OGB’s aim of advancing therapies into clinical trials
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Orange Grove Bio
Siegfried
HQ: Switzerland
Website
- Description: Provider of contract development and manufacturing for active pharmaceutical ingredients and drug products, including intermediates and controlled substances. Services span process development and optimization, formulation and pilot-scale production, registration support, and packaging and logistics for tablets, capsules, sterile vials, ampoules, cartridges, and ointments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Siegfried company profile →
Optivia
HQ: United States
Website
- Description: Provider of contract research services for the pharmaceutical industry, advancing the utility of transporter research across pharmacokinetics, toxicology, therapeutic target discovery, and basic biology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Optivia company profile →
Prolaio
HQ: United States
Website
- Description: Provider of prescriptive analytics-driven HealthTech solutions for continuous cardiac monitoring and risk assessment, including post-discharge heart failure and hypertrophic cardiomyopathy systems, AI-powered predictive analytics for care teams, remote monitoring for clinical studies, and a patient app for data collection, guidance, and reporting to support early intervention and reduce readmissions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prolaio company profile →
Sanner
HQ: Germany
Website
- Description: Provider of primary plastic packaging systems for pharmaceuticals and dietary supplements, offering desiccant capsules (AdCap), canisters, packets (AdPack), plastic tubes with desiccant caps, desiccant closures with glass bottles, and closures for aluminum tubes. Solutions deliver moisture and odor absorption, protection against mechanical damage and unauthorized opening, compatibility with standard dosing systems; aluminum options are airtight, lightproof, and breakproof.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sanner company profile →
Aceto
HQ: United States
Website
- Description: Provider of niche, differentiated specialty materials for life sciences and advanced technology end markets; a global virtual manufacturer operating in nine countries, distributing over 1,100 chemical compounds used by pharmaceutical, nutraceutical, agricultural, and specialty chemical industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aceto company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Orange Grove Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Orange Grove Bio
2.2 - Growth funds investing in similar companies to Orange Grove Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Orange Grove Bio
4.2 - Public trading comparable groups for Orange Grove Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →